Literature DB >> 7522323

Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen.

A M Montgomery1, R A Reisfeld, D A Cheresh.   

Abstract

Human melanoma cells required ligation of the integrin alpha v beta 3 to sustain viability and growth in three-dimensional dermal collagen. Variant melanoma cells, lacking the alpha v subunit, progressed rapidly to apoptosis within this matrix, whereas transfection of these cells with an alpha v cDNA restored alpha v beta 3 expression and prevented apoptosis. Furthermore, inhibition of alpha v beta 3 ligation with a monoclonal antibody promoted cell death. Apoptosis of alpha v(-) cells within this matrix could be overcome by the addition of insulin or serum. However, alpha v(+) melanoma cells had a significant growth advantage in the presence of these growth factors. Initial adhesion of the melanoma cells to type I collagen depended on ligation of alpha 2 beta 1, but these cells can degrade this collagen to expose cryptic alpha v beta 3 binding sites. These findings provide evidence that the survival and growth of transformed cells may be regulated by collagen degradation and integrin-dependent anchorage to this proteolysed matrix.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7522323      PMCID: PMC44705          DOI: 10.1073/pnas.91.19.8856

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  28 in total

1.  Genetics and biochemistry of collagen binding-triggered glandular differentiation in a human colon carcinoma cell line.

Authors:  M Pignatelli; W F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

2.  Biosynthetic and functional properties of an Arg-Gly-Asp-directed receptor involved in human melanoma cell attachment to vitronectin, fibrinogen, and von Willebrand factor.

Authors:  D A Cheresh; R C Spiro
Journal:  J Biol Chem       Date:  1987-12-25       Impact factor: 5.157

Review 3.  Tumor invasion: a consequence of destructive and compositional matrix alterations.

Authors:  B U Pauli; W Knudson
Journal:  Hum Pathol       Date:  1988-06       Impact factor: 3.466

4.  Integrin distribution in malignant melanoma: association of the beta 3 subunit with tumor progression.

Authors:  S M Albelda; S A Mette; D E Elder; R Stewart; L Damjanovich; M Herlyn; C A Buck
Journal:  Cancer Res       Date:  1990-10-15       Impact factor: 12.701

5.  Collagen-platelet interactions: evidence for a direct interaction of collagen with platelet GPIa/IIa and an indirect interaction with platelet GPIIb/IIIa mediated by adhesive proteins.

Authors:  B S Coller; J H Beer; L E Scudder; M H Steinberg
Journal:  Blood       Date:  1989-07       Impact factor: 22.113

6.  Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibitor MI/TIMP-2.

Authors:  Y A DeClerck; T D Yean; H S Lu; J Ting; K E Langley
Journal:  J Biol Chem       Date:  1991-02-25       Impact factor: 5.157

7.  Programmed cell death during regression of the MCF-7 human breast cancer following estrogen ablation.

Authors:  N Kyprianou; H F English; N E Davidson; J T Isaacs
Journal:  Cancer Res       Date:  1991-01-01       Impact factor: 12.701

8.  The role of integrins alpha 2 beta 1 and alpha 3 beta 1 in cell-cell and cell-substrate adhesion of human epidermal cells.

Authors:  W G Carter; E A Wayner; T S Bouchard; P Kaur
Journal:  J Cell Biol       Date:  1990-04       Impact factor: 10.539

Review 9.  Role of collagenous matrices in the adhesion and growth of cells.

Authors:  H K Kleinman; R J Klebe; G R Martin
Journal:  J Cell Biol       Date:  1981-03       Impact factor: 10.539

10.  The vitronectin receptor alpha v beta 3 binds fibronectin and acts in concert with alpha 5 beta 1 in promoting cellular attachment and spreading on fibronectin.

Authors:  I F Charo; L Nannizzi; J W Smith; D A Cheresh
Journal:  J Cell Biol       Date:  1990-12       Impact factor: 10.539

View more
  98 in total

Review 1.  Mechanisms of tumor angiogenesis and therapeutic implications: angiogenesis inhibitors.

Authors:  H Malonne; I Langer; R Kiss; G Atassi
Journal:  Clin Exp Metastasis       Date:  1999-02       Impact factor: 5.150

Review 2.  Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules.

Authors:  G E Davis; K J Bayless; M J Davis; G A Meininger
Journal:  Am J Pathol       Date:  2000-05       Impact factor: 4.307

Review 3.  Adhesion-mediated signaling in the regulation of mammary epithelial cell survival.

Authors:  C H Streuli; A P Gilmore
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-04       Impact factor: 2.673

4.  Identification of gene function and functional pathways by systemic plasmid-based ribozyme targeting in adult mice.

Authors:  Mohammed Kashani-Sabet; Yong Liu; Sylvia Fong; Pierre-Yves Desprez; Shuqing Liu; Guanghuan Tu; Mehdi Nosrati; Chakkrapong Handumrongkul; Denny Liggitt; Ann D Thor; Robert J Debs
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-12       Impact factor: 11.205

5.  Cross talk between beta(1) and alpha(V) integrins: beta(1) affects beta(3) mRNA stability.

Authors:  S F Retta; G Cassarà; M D'Amato; R Alessandro; M Pellegrino; S Degani; G De Leo; L Silengo; G Tarone
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

6.  Inhibition of endothelial cell survival and angiogenesis by protein kinase A.

Authors:  Semi Kim; Manjiri Bakre; Hong Yin; Judith A Varner
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

7.  Protein kinase Cα (PKCα) regulates p53 localization and melanoma cell survival downstream of integrin αv in three-dimensional collagen and in vivo.

Authors:  Stephen D Smith; Martin Enge; Wenjie Bao; Minna Thullberg; Tânia D F Costa; Helene Olofsson; Behxhet Gashi; Galina Selivanova; Staffan Strömblad
Journal:  J Biol Chem       Date:  2012-07-06       Impact factor: 5.157

Review 8.  Manipulating the microvasculature and its microenvironment.

Authors:  Laxminarayanan Krishnan; Carlos C Chang; Sara S Nunes; Stuart K Williams; Jeffrey A Weiss; James B Hoying
Journal:  Crit Rev Biomed Eng       Date:  2013

9.  Phase I and pharmacokinetic study of etaracizumab (Abegrin), a humanized monoclonal antibody against alphavbeta3 integrin receptor, in patients with advanced solid tumors.

Authors:  Catherine Delbaldo; Eric Raymond; Karina Vera; Luz Hammershaimb; Karen Kaucic; Stéphanie Lozahic; Michel Marty; Sandrine Faivre
Journal:  Invest New Drugs       Date:  2007-09-18       Impact factor: 3.850

10.  Tumor-selective response to antibody-mediated targeting of alphavbeta3 integrin in ovarian cancer.

Authors:  Charles N Landen; Tae-Jin Kim; Yvonne G Lin; William M Merritt; Aparna A Kamat; Liz Y Han; Whitney A Spannuth; Alpa M Nick; Nicholas B Jennnings; Michael S Kinch; David Tice; Anil K Sood
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.